Table 5.
13C NMR and partial 1H NMR spectral data for compounds F2 and J2
C | F2 | J2 | Ref. [2] | H | 1 | 2 |
---|---|---|---|---|---|---|
2 | 158.83 | 158.47 | 154.66 | |||
3 | 135.89 | 134.82 | 132.59 | |||
4 | 180.32 | 179.47 | 176.94 | |||
5 | 162.46 | 162.98 | 161.07 | |||
6 | 101.38 | 99.94 | 99.31 | 6 | 3.798 | 3.998 |
7 | 165.57 | 165.76 | 165.05 | |||
8 | 96.99 | 94.91 | 93.85 | 8 | 3.793 | 3.987 |
9 | 160.47 | 158.86 | 156.48 | |||
10 | 106.88 | 105.78 | 102.78 | |||
1′ | 123.97 | 122.93 | 120.89 | |||
2′ | 133.65 | 132.39 | 130.71 | 2′ | 4.983 | 5.40 |
3′ | 117.69 | 116.24 | 115.13 | 3′ | 4.796 | 4.794 |
4′ | 161.11 | 161.37 | 161.00 | |||
5′ | 117.69 | 116.24 | 115.13 | 5′ | 4.796 | 4.794 |
6′ | 133.65 | 132.39 | 130.71 | 6′ | 4.983 | 5.40 |
CC | α-l-Rhamno | α-l-Rhamno | Ref. [2] | H | 1 | 2 |
---|---|---|---|---|---|---|
1″ | 103.09 | 102.15 | 1″ | 3.821 | 4.511 | |
2″ | 72.69 | 72.29 | ||||
3″ | 72.49 | 72.07 | ||||
4″ | 74.35 | 73.87 | ||||
5″ | 71.09 | 69.75 | ||||
6″ | 19.05 | 17.07 | 6″ | 3.354 | 3.526 |
CC | β-d-Gluco (A) | β-d-Gluco | β-d-Gluco | H | 1 | 2 |
---|---|---|---|---|---|---|
1″ | 102.43 | 100.83 | 97.88 | 1″ | 3.806 | 4.006 |
2″ | 81.60 | 82.08 | 81.73 | |||
3″ | 78.42 | 78.19 | 76.04 | |||
4″ | 71.49 | 71.42 | 69.53 | |||
5″ | 78.65 | 77.05 | 76.78 | |||
6″ | 69.53 | 68.13 | 60.48 |
C | β-d-Gluco (B) | β-d-Xylo | β-d-Xylo | H | 1 | 2 |
---|---|---|---|---|---|---|
1″ | 104.70 | 105.25 | 104.44 | 1″ | 4.448 | 4.783 |
2″ | 76.07 | 74.80 | 73.78 | |||
3″ | 77.11 | 76.94 | 76.04 | |||
4″ | 72.16 | 71.01 | 69.37 | |||
5″ | 78.24 | 66.62 | 65.62 | |||
6″ | 63.48 |
The reference substance is kaempferol 3-O-β-d-glucose-(2 → 1)β-d-xyloside; 13C NMR, 125 MHz, solution CD3OD; 1H NMR, 500 MHz, solution CD3OD